SEARCH

SEARCH BY CITATION

References

  • Agteresch H. J., Dagnelie P. C., Van Den Berg J. W. and Wilson J. H. (1999) Adenosine triphosphate: established and potential clinical applications. Drugs 58, 211232.
  • Amadesi S., Nie J., Vergnolle N. et al. (2004) Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia. J. Neurosci. 24, 43004312.
  • Amadio S., D'Ambrosi N., Cavaliere F., Murra B., Sancesario G., Bernardi G., Burnstock G. and Volonte C. (2002) P2 receptor modulation and cytotoxic function in cultured CNS neurons. Neuropharmacology 42, 489501.
  • Bofill-Cardona E., Vartian N., Nanoff C., Freissmuth M. and Boehm S. (2000) Two different signaling mechanisms involved in the excitation of rat sympathetic neurons by uridine nucleotides. Mol. Pharmacol. 57, 11651172.
  • Brown D. A., Filippov A. K. and Barnard E. A. (2000) Inhibition of potassium and calcium currents in neurones by molecularly-defined P2Y receptors. J. Auton Nerv. Syst. 81, 3136.
  • Budd D. C., McDonald J. E. and Tobin A. B. (2000) Phosphorylation and regulation of a Gq/11-coupled receptor by casein kinase 1α. J. Biol. Chem. 275, 19 66719 675.
  • Bünemann M. and Hosey M. M. (1999) G-protein coupled receptor kinases as modulators of G-protein signalling. J. Physiol. 517, 523.
  • Chen B. C. and Lin W. W. (1999) PKCβI mediates the inhibition of P2Y receptor-induced inositol phosphate formation in endothelial cells. Br. J. Pharmacol. 127, 19081914.
  • Chorna N. E., Santiago-Perez L. I., Erb L., Seye C. I., Neary J. T., Sun G. Y., Weisman G. A. and Gonzalez F. A. (2004) P2Y receptors activate neuroprotective mechanisms in astrocytic cells. J. Neurochem. 91, 119132.
  • Davies S. P., Reddy H., Caivano M. and Cohen P. (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351, 95105.
  • Ferguson S. S. (2001) Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol. Rev. 53, 124.
  • Ferguson S. S. and Caron M. G. (1998) G protein-coupled receptor adaptation mechanisms. Semin. Cell Dev. Biol. 9, 119127.
  • Firestein B. L., Xing M., Hughes R. J., Corvera C. U. and Insel P. A. (1996) Heterogeneity of P2u- and P2y-purinergic receptor regulation of phospholipases in MDCK cells. Am. J. Physiol. 271, F610F618.
  • Fischer W., Wirkner K., Weber M. et al. (2003) Characterization of P2X3, P2Y1 and P2Y4 receptors in cultured HEK293-hP2X3 cells and their inhibition by ethanol and trichloroethanol. J. Neurochem. 85, 779790.
  • Garland A. M., Grady E. F., Lovett M., Vigna S. R., Frucht M. M., Krause J. E. and Bunnett N. W. (1996) Mechanisms of desensitization and resensitization of G protein-coupled neurokinin1 and neurokinin2 receptors. Mol. Pharmacol. 49, 438446.
  • Garrad R. C., Otero M. A., Erb L., Theiss P. M., Clarke L. L., Gonzalez F. A., Turner J. T. and Weisman G. A. (1998) Structural basis of agonist-induced desensitization and sequestration of the P2Y2 nucleotide receptor. Consequences of truncation of the C terminus. J. Biol. Chem. 273, 29 43729 444.
  • Grynkiewicz G., Poenie M. and Tsien R. Y. (1985) A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 34403450.
  • Kallal L. and Benovic J. L. (2000) Using green fluorescent proteins to study G-protein-coupled receptor localization and trafficking. Trends Pharmacol. Sci. 21, 175180.
  • Kannan S. (2002) Amplification of extracellular nucleotide-induced leukocyte(s) degranulation by contingent autocrine and paracrine mode of leukotriene-mediated chemokine receptor activation. Med. Hypotheses 59, 261265.
  • Von Kügelgen I. and Wetter A. (2000) Molecular pharmacology of P2Y-receptors. Naunyn Schmiedebergs Arch. Pharmacol. 362, 310323.
  • Luzio J. P., Rous B. A., Bright N. A., Pryor P. R., Mullock B. M. and Piper R. C. (2000) Lysosome–endosome fusion and lysosome biogenesis. J. Cell Sci. 113, 15151524.
  • Milligan G. (1999) Exploring the dynamics of regulation of G protein-coupled receptors using green fluorescent protein. Br. J. Pharmacol. 128, 501510.
  • Moore D. J., Murdock P. R., Watson J. M., Faull R. L., Waldvogel H. J., Szekeres P. G., Wilson S., Freeman K. B. and Emson P. C. (2003) GPR105, a novel Gi/o-coupled UDP-glucose receptor expressed on brain glia and peripheral immune cells, is regulated by immunologic challenge: possible role in neuroimmune function. Brain Res. Mol. Brain Res. 118, 1023.
  • Nicholas R. A. (2001) Identification of the P2Y12 receptor: a novel member of the P2Y family of receptors activated by extracellular nucleotides. Mol. Pharmacol. 60, 416420.
  • Oakley R. H., Laporte S. A., Holt J. A., Barak L. S. and Caron M. G. (1999) Association of β-arrestin with G protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization. J. Biol. Chem. 274, 32 24832 257.
  • Oksche A., Boese G., Horstmeyer A., Furkert J., Beyermann M., Bienert M. and Rosenthal W. (2000) Late endosomal/lysosomal targeting and lack of recycling of the ligand-occupied endothelin B receptor. Mol. Pharmacol. 57, 11041113.
  • Otero M., Garrad R. C., Velazquez B. et al. (2000) Mechanisms of agonist-dependent and -independent desensitization of a recombinant P2Y2 nucleotide receptor. Mol. Cell Biochem. 205, 115123.
  • Pierce K. L., Maudsley S., Daaka Y., Luttrell L. M. and Lefkowitz R. J. (2000) Role of endocytosis in the activation of the extracellular signal-regulated kinase cascade by sequestering and non-sequestering G protein-coupled receptors. Proc. Natl Acad. Sci. USA 97, 14891494.
  • Post S. R., Aguila-Buhain O. and Insel P. A. (1996) A key role for protein kinase A in homologous desensitization of the β2-adrenergic receptor pathway in S49 lymphoma cells. J. Biol. Chem. 271, 895900.
  • Powell A. D., Teschemacher A. G. and Seward E. P. (2000) P2Y purinoceptors inhibit exocytosis in adrenal chromaffin cells via modulation of voltage-operated calcium channels. J. Neurosci. 20, 606616.
  • Ralevic V. and Burnstock G. (1998) Receptors for purines and pyrimidines. Pharmacol. Rev. 50, 413492.
  • Rohatgi T., Sedehizade F., Reymann K. G. and Reiser G. (2004) Protease-activated receptors in neuronal development, neurodegeneration, and neuroprotection: thrombin as signaling molecule in the brain. Neuroscientist 10, 501512.
  • Schonthal A. H. (1998) Role of PP2A in intracellular signal transduction pathways. Front. Biosci. 3, D1262D1273.
  • Spampinato S., Di Toro R., Alessandri M. and Murari G. (2002) Agonist-induced internalization and desensitization of the human nociceptin receptor expressed in CHO cells. Cell Mol. Life Sci. 59, 21722183.
  • Sromek S. M. and Harden T. K. (1998) Agonist-induced internalization of the P2Y2 receptor. Mol. Pharmacol. 54, 485494.
  • Szekeres P. G., Koenig J. A. and Edwardson J. M. (1998) Involvement of receptor cycling and receptor reserve in resensitization of muscarinic responses in SH-SY5Y human neuroblastoma cells. J. Neurochem. 70, 16941703.
  • Tulapurkar M. E., Schäfer R., Hanck T., Flores R. V., Weisman G. A., Gonzalez F. A. and Reiser G. (2005) Endocytosis mechanism of P2Y2 nucleotide receptor tagged with green fluorescent protein: clathrin and actin cytoskeleton dependence. Cell Mol. Life Sci. 62, 13881399.
  • Van der Weyden L., Adams D. J., Luttrell B. M., Conigrave A. D. and Morris M. B. (2000) Pharmacological characterisation of the P2Y11 receptor in stably transfected haematological cell lines. Mol. Cell Biochem. 213, 7581.
  • Vöhringer C., Schäfer R. and Reiser G. (2000) A chimeric rat brain P2Y1 receptor tagged with green-fluorescent protein: high-affinity ligand recognition of adenosine diphosphates and triphosphates and selectivity identical to that of the wild-type receptor. Biochem. Pharmacol. 59, 791800.
  • Volonte C., Amadio S., Cavaliere F., D'Ambrosi N., Vacca F. and Bernardi G. (2003) Extracellular ATP and neurodegeneration. Curr. Drug Targets CNS Neurol. Disord. 2, 403412.
  • Wang H. and Reiser G. (2003) Thrombin signaling in the brain: the role of protease-activated receptors. Biol. Chem. 384, 193202.
  • Wang H., Ubl J. J. and Reiser G. (2002) Four subtypes of protease-activated receptors, co-expressed in rat astrocytes, evoke different physiological signaling. Glia 37, 5363.
  • Weisshart K., Jungel V. and Briddon S. J. (2004) The LSM 510 META–ConfoCor 2 system: an integrated imaging and spectroscopic platform for single-molecule detection. Curr. Pharm. Biotechnol. 5, 135154.
  • Wirkner K., Schweigel J., Gerevich Z., Franke H., Allgaier C., Barsoumian E. L., Draheim H. and Illes P. (2004) Adenine nucleotides inhibit recombinant N-type calcium channels via G protein-coupled mechanisms in HEK293 cells; involvement of the P2Y13 receptor-type. Br. J. Pharmacol. 141, 141151.
  • Zamani M. R. and Bristow D. R. (1996) The histamine H1 receptor in GT1-7 neuronal cells is regulated by calcium influx and KN-62, a putative inhibitor of calcium/calmodulin protein kinase II. Br. J. Pharmacol. 118, 11191126.
  • Zolnierowicz S. (2000) Type 2A protein phosphatase, the complex regulator of numerous signaling pathways. Biochem. Pharmacol. 60, 12251235.
  • Zündorf G., Schäfer R., Vöhringer C., Halbfinger E., Fischer B. and Reiser G. (2001) Novel modified adenosine 5′-triphosphate analogues pharmacologically characterized in human embryonic kidney 293 cells highly expressing rat brain P2Y1 receptor: biotinylated analogue potentially suitable for specific P2Y1 receptor isolation. Biochem. Pharmacol. 61, 12591269.